Please wait…

Login required

Username or email:

To use this function please log-in
If you haven't got an account on, you have the opportunity to register regist here for free.

add instrument

DekaLux-BioTech TF

DekaLux-BioTech TF

ISIN LU0348461897 | WKN DK1A3Z | Mnemonic FKQX | Type fund
20/10/2017 12:49
Bid Ask
This product is subject to quotation restrictions.
Change from Prev. Day -2.90 EUR / -0.74%
Spread absolute / relative 0,00 / 0,00%

Net Asset Value

Previous Day 391.44 EUR Date 20/10/2017

Price Information

Last Price 390.396
Date / Time 20.10.2017 / 12:49:18
Price -
Volume in euro -
Volume Size -
High 0.000
Low 0.000
52 week High 403.091
52 week Low 314.059
Trading Hours 09:00 - 17:30

Price History

Date Opening Price Closing Price Daily High Daily Low Volume (pcs.)
20/10/2017 389.86 390.40 390.40 389.14 76
19/10/2017 392.76 393.30 393.30 392.76 52
18/10/2017 395.71 395.22 395.71 395.22
17/10/2017 389.17 393.51 393.51 388.25 8
16/10/2017 394.96 389.17 394.96 389.17 50


Management Fee 1.25 %
Custodian Fee 0.10 %
Capital forming savings possible? no
Savings Plan yes
Distribution Distributring

Frankfurt Trading Parameters

Continous Quotation no
Minimum tradeable Unit 1

Funds Category Comparison

Rating for DekaLux-BioTech TF

€uro FondsNote -
Lipper Leaders, 3 years -
Lipper Leaders, 5 years -
Lipper Leaders, 10 years -
Lipper Leaders, overall -


Fundamental Data

ISIN LU0348461897
Name DekaLux-BioTech TF
Investment Company Deka International S.A.
Issued in Luxemburg
Issue Date 02/06/2008
Category Aktienfonds Biotechnologie
currency EUR
Volume 154,211,593.10
Depositary Bank DekaBank Deutsche Girozentrale, Luxembourg S.A.
Paying Agent -
Fund Management Deka Team
Fiscal Year-End 30.06.
Last Update 26/07/2017

Investment policy

invest like DekaLux-BioTech TF: Das Fondsmanagement investiert weltweit in Aktien von Unternehmen der Biotechnologiebranche. Neben Unternehmen, die sich in den Bereichen Erforschung, Entwicklung und Produktion von medizinischen Produkten engagieren, werden unter anderem Werte der innovativen Bereiche Gentechnik und Gentherapie berücksichtigt. Als Beimischung kommen darüber hinaus Investitionen in verwandten Segmenten, wie Medizintechnik und Pharmaindustrie, in Betracht.

The following Disclaimer and Information has been prepared by Voltabox AG (the “Issuer”) for the purpose of publishing THE securities prospectus by the issuer. Deutsche Boerse AG does not assume any responsibility for the content of the issuer`s Disclaimer and information.


Important Information


The information contained on the following web pages is directed only at persons who are resident of or domiciled in the Federal Republic of Germany (“Germany”) or the Grand Duchy of Luxembourg (“Luxembourg”). The following information does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for any securities. No offer of securities of the Issuer is being, or will be, made to the public outside Germany and Luxembourg. The offer in Germany and Luxembourg is being made solely on the basis of the securities prospectus (including any amendments thereto) which has been approved by the German Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and which has been published on the Issuer’s website. Any investment decision regarding the publicly offered securities of the Issuer should only be made on the basis of the securities prospectus. The securities prospectus is available free of charge from the Issuer (Artegastraße 1, 33129 Delbrück, Germany; Tel.: +49 (0)5250 9930-900; Fax: +49 (0)5250 9762-102) and on the Issuer’s website (

The information contained on the following web pages is not an offer of securities for sale or a solicitation of an offer to purchase securities in the United States of America (“United States”), Canada, Australia or Japan. The Issuer’s shares, and the securities offered in the course of the offer, have not been and will not be registered under the US Securities Act of 1933, as amended (“Securities Act”), or with any other securities regulatory authority of any state or other jurisdiction of the United States and may not be offered, sold or delivered within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws. The Issuer does not intend to register the offer or parts thereof in the United States or make an offer to the public in the United States, Canada, Australia or Japan.

The information contained on the following web pages is not for distribution to persons who are located in the United States, Canada, Australia or Japan or any other jurisdiction where the offer of the securities to the public is not taking place. Any violation of these restrictions may constitute a breach of the securities laws of these countries. The copying, forwarding or other transmission of the content of the following web pages is prohibited.

By clicking the "I AGREE" button below, you warrant that (i) you have read and accepted the foregoing information and restrictions in full and (ii) you are a resident of or domiciled in Germany or Luxembourg, and (iii) you agree not to distribute or forward the information contained on the following web pages to any person who is not a resident of or domiciled in Germany or Luxembourg.


We regret that, due to regulatory restrictions, we are unable to provide you with access to the following web pages.